Amgen Wins First EU Avastin Biosimilar Approval, But When Will It Launch?

 
• By Lucie Ellis-Taitt
  
Fieldfare
Early bird gets the worm: Amgen/Allergan are first to win EU approval for Avastin biosimilar • Source: Shutterstocl
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip